IL33 and obesity due to melanocortin 4 receptor deficiency: However, Pereira et al. recently reported that the treatment of subcutaneous adipose tissues with IL–33 ex-vivo decreased glucose uptake in isolated adipocytes, where analyses of IL–33 expression showed positive associations between IL–33, insulin resistance, obesity, and T2DM [38].